Business
- Global report
Regulatory
Pharmacovigilance
Manufacturing
- GMP
- Quality assurance
R&D
- API
- Excipients
- Trials
- Drug Delivery
- Technology
Companies
EIPG Newsletter

Search

Who we are
How to use and read

Business
- Global report
Regulatory
Pharmacovigilance
Manufacturing
- GMP
- Quality assurance
R&D
- API
- Excipients
- Trials
- Drug Delivery
- Technology
Companies
EIPG Newsletter

Home Authors Posts by Redazione

Redazione

1 POSTS 0 COMMENTS

HAZEL® GATEWAY GW-MB1: simplify the validation of recovery times in...

Redazione - 29 March 2021

Recent Posts

HAZEL® GATEWAY GW-MB1: simplify the validation of recovery times in airlocks
EIPG: Upcoming events and a call for consultation
The economic footprint of the biotechnology industry in Europe: Focus in Pharma
Comments to the public consultation on the new HERA agency
Structured dialogue with the EU Commission to prevent shortages

Latest Updates

2018/04 – December
2018/03 – November
2018/02 – June
2018/01 – May

Subscribe to our newsletter

Translate

NCF – Notiziario Chimico Farmaceutico

NCF

Inibitori enzimatici per potenziare il sistema immunitario contro i tumori
Our battle in a bottle: le soluzioni di Marchesini Group per il confezionamento dei vaccini
Inaugurato a Pomezia “Labio 4.0”, il nuovo centro R&D di Alfasigma
EFPIA commenta la proposta di report sul Beating Cancer Plan
I risultati di anakinra per il trattamento delle polmoniti da Covid-19

© 2020 Tecniche Nuove Spa • Tutti i diritti riservati. Sede legale: Via Eritrea 21 - 20157 Milano. Capitale sociale: 5.000.000 euro interamente versati. Codice fiscale, Partita Iva e Iscrizione al Registro delle Imprese di Milano: 00753480151